- Home
- ATRC vs CIM Comparison
ATRC vs CIM Comparison
Compare ATRC & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- CIM
- Stock Information
- Founded
- ATRC 2000
- CIM 2007
- Country
- ATRC United States
- CIM United States
- Employees
- ATRC N/A
- CIM N/A
- Industry
- ATRC Medical/Dental Instruments
- CIM Real Estate Investment Trusts
- Sector
- ATRC Health Care
- CIM Real Estate
- Exchange
- ATRC Nasdaq
- CIM Nasdaq
- Market Cap
- ATRC 1.1B
- CIM 1.2B
- IPO Year
- ATRC 2005
- CIM 2007
- Fundamental
- Price
- ATRC $40.61
- CIM $15.31
- Analyst Decision
- ATRC Strong Buy
- CIM Hold
- Analyst Count
- ATRC 9
- CIM 2
- Target Price
- ATRC $43.00
- CIM $16.00
- AVG Volume (30 Days)
- ATRC 618.4K
- CIM 485.8K
- Earning Date
- ATRC 02-12-2025
- CIM 02-12-2025
- Dividend Yield
- ATRC N/A
- CIM 9.37%
- EPS Growth
- ATRC N/A
- CIM 117.60
- EPS
- ATRC N/A
- CIM 3.36
- Revenue
- ATRC $447,573,000.00
- CIM $442,341,000.00
- Revenue This Year
- ATRC $18.02
- CIM N/A
- Revenue Next Year
- ATRC $12.93
- CIM $10.53
- P/E Ratio
- ATRC N/A
- CIM $4.51
- Revenue Growth
- ATRC 17.56
- CIM 44.27
- 52 Week Low
- ATRC $18.94
- CIM $11.29
- 52 Week High
- ATRC $43.11
- CIM $16.89
- Technical
- Relative Strength Index (RSI)
- ATRC 61.66
- CIM 58.60
- Support Level
- ATRC $39.71
- CIM $14.47
- Resistance Level
- ATRC $43.11
- CIM $15.08
- Average True Range (ATR)
- ATRC 1.86
- CIM 0.26
- MACD
- ATRC 0.15
- CIM 0.09
- Stochastic Oscillator
- ATRC 63.10
- CIM 67.74
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.